Jackson Creek Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,149
Closed -$361K 349
2025
Q3
$361K Sell
14,149
-4,290
-23% -$106K 0.1% 248
2025
Q2
$447K Buy
18,439
+54
+0.3% +$1.26K 0.12% 240
2025
Q1
$466K Buy
18,385
+4,477
+32% +$117K 0.15% 236
2024
Q4
$369K Sell
13,908
-2,364
-15% -$64.1K 0.11% 263
2024
Q3
$471K Buy
+16,272
New +$475K 0.14% 226
2022
Q4
Sell
-9,878
Closed -$432K 366
2022
Q3
$432K Buy
9,878
+54
+0.5% +$2.62K 0.2% 235
2022
Q2
$496K Sell
9,824
-4,438
-31% -$226K 0.2% 235
2022
Q1
$738K Sell
14,262
-602
-4% -$31.2K 0.27% 195
2021
Q4
$878K Sell
14,864
-328
-2% -$16.3K 0.31% 183
2021
Q3
$653K Sell
15,192
-494
-3% -$21.9K 0.24% 202
2021
Q2
$614K Sell
15,686
-29
-0.2% -$1.13K 0.23% 211
2021
Q1
$569K Buy
15,715
+456
+3% +$16.2K 0.2% 224
2020
Q4
$562K Sell
15,259
-890
-6% -$32.6K 0.22% 217
2020
Q3
$562K Buy
+16,149
New +$566K 0.25% 215

Other funds holding PFE

Jackson Creek Investment Advisors's PFE Position: Q4 2025 in Review

Jackson Creek Investment Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 14,149 shares — an estimated $361K sold.

Jackson Creek Investment Advisors first reported a position in PFE in Q3 2020 and held it in 14 quarters. The position peaked at $878K in Q4 2021. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Jackson Creek Investment Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 14,149 Pfizer shares in Q4 2025, an estimated $361K.
  • Jackson Creek Investment Advisors first reported a position in Pfizer in Q3 2020 and held it in 14 quarters.
  • Jackson Creek Investment Advisors's Pfizer position peaked at $878K in Q4 2021.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Jackson Creek Investment Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.